Insights

Growth and Expansion BioGenix's recent partnership with Dr. Reddy’s Laboratories for the development of novel CAR-T cell therapies indicates a strategic move towards expanding its portfolio into advanced cell therapy markets, presenting opportunities for tailored biotechnological solutions and collaborations.

Market Positioning Focusing on ethically sound, umbilical cord derived regenerative products, BioGenix appeals to partners and clients seeking safe, innovative regenerative medicine options, creating potential for partnerships with hospitals, clinics, and research institutions invested in ethical biotech solutions.

Technological Infrastructure Utilizing cloud services like Amazon Web Services and Google Cloud signifies a robust technological foundation, enabling scalable data management and research capabilities that can attract clients needing reliable biotech research and clinical data solutions.

Financial Growth Potential With current revenues estimated between $1 million and $10 million, and active high-profile collaborations, there is significant potential for growth, making BioGenix an attractive prospect for investors or partners interested in emerging biotech innovations.

Industry Alignment Operating within the competitive regenerative and cell therapy sectors, BioGenix’s strategic focus on ethically sourced products aligns with industry trends toward sustainable and responsible healthcare solutions, offering opportunities to position as a leader in the regenerative medicine market.

BioGenix Tech Stack

BioGenix uses 8 technology products and services including Amazon Web Services, oEmbed, Module Federation, and more. Explore BioGenix's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • oEmbed
    Dev Tools
  • Module Federation
    Development
  • Font Awesome
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • Floating UI
    Javascript Libraries
  • Elementor
    Page Builders
  • Priority Hints
    Performance

BioGenix's Email Address Formats

BioGenix uses at least 1 format(s):
BioGenix Email FormatsExamplePercentage
First.Last@biogenix.comJohn.Doe@biogenix.com
41%
FLast@biogenix.comJDoe@biogenix.com
12%
First@biogenix.comJohn@biogenix.com
6%
First.Last@biogenix.comJohn.Doe@biogenix.com
41%

Frequently Asked Questions

Where is BioGenix's headquarters located?

Minus sign iconPlus sign icon
BioGenix's main headquarters is located at Houston, Texas United States. The company has employees across 4 continents, including North AmericaAsiaAfrica.

What is BioGenix's official website and social media links?

Minus sign iconPlus sign icon
BioGenix's official website is biogenix.com and has social profiles on LinkedIn.

What is BioGenix's SIC code NAICS code?

Minus sign iconPlus sign icon
BioGenix's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioGenix have currently?

Minus sign iconPlus sign icon
As of March 2026, BioGenix has approximately 53 employees across 4 continents, including North AmericaAsiaAfrica. Key team members include Chief Executive Officer: N. F.Vice President Of Operations: J. L.Vice President - Stem Cell Therapy: M. S.. Explore BioGenix's employee directory with LeadIQ.

What industry does BioGenix belong to?

Minus sign iconPlus sign icon
BioGenix operates in the Biotechnology Research industry.

What technology does BioGenix use?

Minus sign iconPlus sign icon
BioGenix's tech stack includes Amazon Web ServicesoEmbedModule FederationFont AwesomeGoogle CloudFloating UIElementorPriority Hints.

What is BioGenix's email format?

Minus sign iconPlus sign icon
BioGenix's email format typically follows the pattern of First.Last@biogenix.com. Find more BioGenix email formats with LeadIQ.

When was BioGenix founded?

Minus sign iconPlus sign icon
BioGenix was founded in 2011.

BioGenix

Biotechnology ResearchTexas, United States51-200 Employees

BioGenix grew out of the recognition of the important potential of regenerative medicine in giving hope to patients who suffer from past injuries, chronic conditions, or degenerative disease. Out of this potential grew the demand for safe, reliable, ethically sound regenerative products -- and BioGenix was up to the task.

Working directly with hospitals participating in umbilical cord tissue donation programs and partnering with a trusted, sterile FDA registered lab, we turned concept into reality, bringing BioGenix regenerative products to physicians across many medical specialties domestically and around the world. 

By choosing to use only umbilical cord derived regenerative medicine products, we harness the medical advantages of growth-factor rich tissue while circumventing invasive procedures and providing a product that aligns with our ethics.

Section iconCompany Overview

Headquarters
Houston, Texas United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
51-200

Section iconFunding & Financials

  • $1M$10M

    BioGenix's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    BioGenix's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.